SPOTLIGHT -
Slideshow
Author(s):
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists
Treating ‘Morally Objectionable’ Patients
The Enduring Impact of Early Adversity on Psychosis Risk
What Will the Future of Alzheimer Disease Treatment Look Like?
Coordinated Specialty Care: Paving the Way for Psychosis Recovery
Major Changes in the Treatment of Schizophrenia: A Long Time in the Making